Miracle Biotech is an industry-leading cell therapy innovator, specializing in universal CAR-T treatments for autoimmune diseases, blood cancers, and solid tumors.
MORE
Research and Development & Production
We are committed to developing the next generation of safe, effective, and ready-to-use UCAR-T cell therapy products
robusT®Platform
The robusT® platform is a self-developed cell therapy drug development platform by Miracle Biotech, incorporating four groundbreaking technologies—Editing, Bi-CAR, EscapeeSpan—that enhance product safety and efficacy.
MORE
UCAR-T Products
Miracle Biotech is developing UCAR-T cell therapy products for a variety of immune diseases, as well as solid tumors and hematological cancers.
MORE
R&D Pipeline
Miracle Biotech is advancing multiple R&D pipelines simultaneously, with submissions in both China and the U.S.